Background illustration for clinical trials search

Paid Clinical Trials Dallas

Discover 1,917 paid clinical trials in Dallas, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer

for
Gastro-esophageal Junction (GEJ) Cancer, Esophagus Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07700420

Phase1, Recruiting
New

Effects of Beef-Forward Ready-to-Eat Meals on Recovery Following Simulated Fire Suppression Activities

for
Physical Performance Parameters, Exercise Recovery, Cognition,
Location: Fort Worth TX, Huntsville TX
Sponsor: Sam Houston State University

Sex: All

Age: 18 - 60

Code: NCT07822048

Recruiting
New

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

for
Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension,
Location: McKinney TX, Cypress TX, Houston TX, Olive Branch MS,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07783802

Phase2, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Fort Worth TX, Tyler TX, Shreveport LA,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase3, Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: Fort Worth TX, Austin TX, Tulsa OK, San Antonio TX,
Sponsor: Kartos Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT05797831

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Dallas TX, Tyler TX, Austin TX, Houston TX,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Worth TX, Austin TX, Tulsa OK, Webster TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase3, Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Fort Worth TX, Tyler TX, Austin TX, Oklahoma City OK,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase3, Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Fort Worth TX, Oklahoma City OK, St Louis MO,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase2, Recruiting
New

A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

for
Ovarian Cancer, Ovarian Neoplasms, Peritoneal Cancer,
Location: Fort Worth TX, Washington D.C. DC
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07776691

Phase3, Recruiting

Clinical Data Registry of Amblyopia Patients on Luminopia Treatment

for
Amblyopia
Location: Fort Worth TX, Crestview FL, Indianapolis IN,
Sponsor: Luminopia

Sex: All

Age: 0+

Code: NCT06429280

Recruiting

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Fort Worth TX, Indianapolis IN, Sarasota FL, Buffalo NY,
Sponsor: InduPro, Inc.

Sex: All

Age: 18+

Code: NCT07602842

Phase1, Phase2, Recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Fort Worth TX, Nashville TN, Englewood CO,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06462794

Phase1, Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumor
Location: Fort Worth TX, Austin TX, Houston TX, Grand Rapids MI,
Sponsor: Pliant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06270706

Phase1, Recruiting

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07517198

Phase1, Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Fort Worth TX, Denton TX, Tyler TX, Austin TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361497

Phase3, Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: Fort Worth TX, Houston TX, San Antonio TX, St Louis MO,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase2, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Fort Worth TX, Tyler TX, Austin TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

for
Solid Tumours
Location: Fort Worth TX, San Antonio TX, Sioux Falls SD,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07160725

Phase1, Phase2, Recruiting

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Fort Worth TX, San Antonio TX, Westwood KS,
Sponsor: Corcept Therapeutics

Sex: All

Age: 18+

Code: NCT07259317

Phase2, Recruiting

Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.

These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.

Why choose Dallas for clinical trials?

Dallas offers distinct advantages for those considering participation in clinical trials. The city's growing health sciences industry and diverse population provides a wide range of participants, which improves the accuracy and applicability of research findings. Dallas is also renowned for its innovative research landscape, with a strong emphasis on medical advancements and groundbreaking studies.

Common conditions studied in Dallas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Dallas